retatrutide phase 2 trial new england journal of medicine Cristobal Morales on X: "Triple Hormone Receptor Agonist #Retatrutide for Obesity A @NEJM @LillyTrials At 48 weeks, the least-squares mean percentage change in the groups was −8.7% in Retatrutide produces up to 30.3%

Injectable GLP-1s and Breast Milk Many injectable GLP-1 medications are large peptide molecules, which naturally limits how much can pass into breast milk

10.1002/btpr.640 61 LeeC

Preliminary studies show promising reductions in body weight, apneahypopnea index (AHI), and systemic inflammation, although long-term trials remain warranted

Understanding food noise: how to silence it without Ozempic Tapeworm is nature's ozempic: netizens react to viral video of raw food diet eater 3 ways weight management medication will reshape nutrition in 2025 Semaglutide: a game-changer in the fight against obesity How weight loss medications like Ozempic could help reduce substance use Fake Ozempic: SAHPRA warning and how to detect counterfeits UK proposes weight loss jabs for unemployed obese individuals to boost job prospects The Ozempic craze: Are celebrity endorsements driving unrealistic weight-loss expectations